Scholars Central

Conference abstractPublished 13 Jun 2018

Perspective on neurobiological and clinical early indicators of mild cognitive decline and alzheimer′s disease

Authors: Jigar Jogia

American University in Dubai, UAE

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

There is a need for early diagnosis, monitoring and treatment of AlzheimerâÂ?Â?s Disease (AD) and Mild Cognitive Impairment (MCI). Traditional assessments of cognitive decline have been found to lack sensitivity and accuracy in differentiating varying stages of Dementia and cognitive decline as well as being time consuming in their administration. Key components of cognition namely memory and executive function have been identified as most predicative of AD status. Brief cognitive screening tools such as the Montreal cognitive assessment have been recommended both as a primary clinical and research assessment offering more sensitivity in differentiating AD and MCI. However, overlapping clinical features and impairments in cognitive processing suggest a need for biological risk factors. Neurobiological indicators of cognitive deterioration have been identified implicating measures of cerebrospinal fluid and temporal lobe atrophy as potential biomarkers of early clinical phases of AD and predictors of cognitive decline. Evidence shows the utility of automated classification methods in processing and analyzing multivariate neuroimaging data which improves our accuracy for the prediction of conversion of MCI to AD. In this review, we discuss the clinical usefulness of such approaches and the need for big data and multi-site studies in improving our understanding of AD neuropathology and confirming pathophysiological mechanisms that can reliably be used to differentiate MCI and AD and predict disease progression and cognitive decline.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Alzheimers Disease & Parkinsonism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Jigar Jogia”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels